Filgrastim is used for: Myelosuppressive chemotherapy; Acute Myeloid Leukemia receiving induction or consolidation chemotherapy; Peripheral blood progenitor cell collection and therapy; Severe Neutropenia; Bone marrow transplantation; HIV infection.
Recorded in the NepalDoc medicine catalog for Filgrastim.
NYPOZI is a leukocyte growth factor indicated to: Decrease the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a significant incidence of severe neutropenia with fever Reduce the time to neutrophil recovery and the duration of fever…
From the U.S. FDA-approved label for Filgrastim. Full label: DailyMed.
NYPOZI is a leukocyte growth factor indicated to: Decrease the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a significant incidence of severe neutropenia with fever Reduce the time to neutrophil recovery and the duration of fever, following induction or consolidation chemotherapy treatment of patients with acute myeloid leukemia (AML) Reduce the duration of neutropenia and neutropenia-related clinical sequelae, e.g., febrile neutropenia…
From the U.S. FDA-approved label for Filgrastim. Full label: DailyMed.
Patients with cancer receiving myelosuppressive chemotherapy or induction and/or consolidation chemotherapy for AML Recommended starting dose is 5 mcg/kg/day by subcutaneous injection, short intravenous infusion (15 to 30 minutes), or continuous intravenous infusion. See Full Prescribing Information for recommended dosage adjustments and timing of administration Patients with cancer undergoing bone marrow transplantation: 10 mcg/kg/day given as an intravenous infusion no longer than 24 hours.
Directions from the U.S. FDA-approved label for Filgrastim — your doctor or pharmacist may advise differently.
NYPOZI is contraindicated in patients with a history of serious allergic reactions to human granulocyte colony-stimulating factors such as filgrastim products or pegfilgrastim products. Patients with a history of serious allergic reactions to human granulocyte colony-stimulating factors such as filgrastim products or pegfilgrastim products
Excerpt from the U.S. FDA-approved label for Filgrastim. Talk to a pharmacist or doctor before use.
Fatal splenic rupture: Evaluate patients who report left upper abdominal or shoulder pain for an enlarged spleen or splenic rupture. Acute respiratory distress syndrome (ARDS): Evaluate patients who develop fever and lung infiltrates or respiratory distress for ARDS. Discontinue NYPOZI in patients with ARDS. Serious allergic reactions, including anaphylaxis: Permanently discontinue NYPOZI in patients with serious allergic reactions. Fatal sickle cell crises: Discontinue NYPOZI if sickle cell crisis occurs. Glomerulonephritis: Evaluate and consider dose-reduction or interruption of NYPOZI if causality is likely.
Warnings and precautions excerpt from the U.S. FDA-approved label for Filgrastim — not a complete list. Talk to a pharmacist or doctor before use.
The following serious adverse reactions are discussed in greater detail in other sections of the labeling: Splenic Rupture Acute Respiratory Distress Syndrome Serious Allergic Reactions Sickle Cell Disorders Glomerulonephritis Alveolar Hemorrhage and Hemoptysis Capillary Leak Syndrome Myelodysplastic Syndrome Acute Myeloid Leukemia Thrombocytopenia Leukocytosis Cutaneous Vasculitis Aortitis Most common adverse reactions in…
Excerpt from the U.S. FDA-approved label for Filgrastim — not a complete list. Talk to a pharmacist or doctor about side effects.
3 brands · 3 makers in the NepalDoc catalog — see the full Filgrastim guide →
Storage: Store NYPOZI in the refrigerator at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light.
Storage information from the U.S. FDA-approved label for Filgrastim.
What is Grafeel?
Grafeel 5mg Tablet is a Filgrastim medicine made by Dr. Reddy's Laboratories. It comes as 5mg Tablet.
What is Grafeel used for?
Filgrastim is used for Myelosuppressive chemotherapy, Acute Myeloid Leukemia receiving induction or consolidation chemotherapy, Peripheral blood progenitor cell collection and therapy, Severe Neutropenia, Bone marrow transplantation, HIV infection.
What is the generic name of Grafeel?
The generic name of Grafeel is Filgrastim.
Which brands of Filgrastim are available in Nepal?
3 brands of Filgrastim are listed in the NepalDoc catalog, from 3 makers — including NEUPOGEN 30MU Injection, NUFIL 300 mg Injection.
What are the side effects of Filgrastim?
The following serious adverse reactions are discussed in greater detail in other sections of the labeling: Splenic Rupture Acute Respiratory Distress Syndrome Serious Allergic Reactions Sickle Cell Disorders Glomerulonephritis Alveolar Hemorrhage and Hemoptysis Capillary Leak Syndrome Myelodysplastic Syndrome Acute Myeloid Leukemia Thrombocytopenia Leukocytosis Cutaneous Vasculitis Aortitis Most common adverse reactions in…
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
